EDITAS MEDICINE, INC. Increase (Decrease) in Other Operating Liabilities
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Other Operating Liabilities of $1.27 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2025-03-05
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for the quarter ending 2024-03-31 was $1.67M.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for the quarter ending 2023-03-31 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-12-31 was -$3.14M, a 379.00% decline year-over-year.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for the quarter ending 2020-09-30 was -$891.00K, a 269.71% decline year-over-year.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for fiscal 2024 was $1.27M, a 29.39% decline from fiscal 2023.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for fiscal 2023 was $1.80M.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for fiscal 2022 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in other operating liabilities for fiscal 2021 was $0.00.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2024-12-31 | $1.27M 10-K · filed 2025-03-05 | |||
| 2024-03-31 | $1.67M 10-Q · filed 2024-05-08 | |||
| 2023-12-31 | $1.80M 10-K · filed 2025-03-05 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-05 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-28 | |||
| 2020-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$4.03M derived: sum of 2 quarters · filed 2023-02-22 | -$3.52M derived: sum of 3 quarters · filed 2023-02-22 | -$2.68M 10-K · filed 2023-02-22 |
| 2020-09-30 | -$891.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$380.00K derived: sum of 2 quarters · filed 2021-11-09 | $453.00K 10-Q · filed 2021-11-09 | $1.58M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $511.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $1.34M 10-Q · filed 2021-08-05 | $2.47M derived: sum of 3 quarters · filed 2022-02-24 | $2.99M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $833.00K 10-Q · filed 2021-05-06 | $1.96M derived: sum of 2 quarters · filed 2022-02-24 | $2.48M derived: sum of 3 quarters · filed 2022-02-24 | $1.60M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.65M derived: sum of 2 quarters · filed 2022-02-24 | $771.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.65M 10-K · filed 2022-02-24 |
| 2019-09-30 | $525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$353.00K derived: sum of 2 quarters · filed 2020-11-06 | $528.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$878.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.00K 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $881.00K 10-Q · filed 2020-05-08 | |||
| 2018-12-31 | $1.03M 10-K · filed 2021-02-26 | |||
| 2017-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | -$13.00K 10-K · filed 2020-02-26 | ||
| 2017-09-30 | -$21.00K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |